ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,268.00
1.36%
Dow Jones
40,421.36
0.33%
Brent Oil
81.515
-0.93%
Bitcoin
67,721.02
-0.64%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuBase Therapeutics Inc (NBSE)

  7. NeuBase Therapeutics Inc (NBSE) News

NBSE

NeuBase Therapeutics (NBSE)

NeuBase Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NBSE
DateTimeSourceHeadlineSymbolCompany
07/03/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NBSENeuBase Therapeutics Inc
07/03/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20245:25PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:NBSENeuBase Therapeutics Inc
06/27/20245:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20245:18PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20245:16PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20245:15PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20244:53PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20244:48PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20244:47PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NBSENeuBase Therapeutics Inc
06/27/20244:46PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
06/03/20244:08PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
05/31/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
05/22/20244:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
05/16/202410:07AMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NBSENeuBase Therapeutics Inc
05/13/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
05/06/20247:30AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
04/05/20244:05PMGlobeNewswire Inc.NeuBase Therapeutics Announces Receipt of Notice from NasdaqNASDAQ:NBSENeuBase Therapeutics Inc
03/07/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
02/23/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
01/26/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
01/17/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
12/28/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
12/28/20236:15AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NBSENeuBase Therapeutics Inc
12/22/20236:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
11/27/20239:00AMGlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:NBSENeuBase Therapeutics Inc
11/09/20234:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NBSENeuBase Therapeutics Inc
11/06/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
11/06/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
10/20/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NBSE

Your Recent History

USOTC
IDVV
International Endeavors (PK)
USOTC
ITUP
Interups (CE)
USOTC
MGON
Megola (PK)
NYSE
AMC
AMC Entertainment
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
GRLT
Grillit (PK)
USOTC
HIRU
Hiru (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
CNNA
Cann American (CE)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
CRTG
Coretec (QB)
USOTC
NBRI
North Bay Resources (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
LWLG
Lightwave Logic
USOTC
SHMP
NaturalShrimp (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved